Skip to main content
OpenTrials

Clinical trial condition

Bronchial Neoplasms

Explore clinical trials studying Bronchial Neoplasms. Study availability and eligibility vary by location and protocol.

5,269 public trials 1,193 recruiting studies
Refine in advanced search Browse all conditions

Bronchial Neoplasms trial results

Completed

Efficacy and Safety of Pembrolizumab Plus Investigational Agents in Combination With Chemotherapy as First-Line Treatment in Extensive-Stage Small Cell Lung Cancer (ES-SCLC) (MK-3475-B99/ KEYNOTE-B99)

NCT04924101

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Lung Diseases, +9 more
Locations
  • Banner MD Anderson Cancer Center ( Site 0102) Gilbert, Arizona, United States
  • University of Colorado Anschutz Medical Campus ( Site 0104) Aurora, Colorado, United States
  • Georgia Cancer Specialists ( Site 0106) Atlanta, Georgia, United States
  • Parkview Research Center at Parkview Regional Medical Center ( Site 0130) Fort Wayne, Indiana, United States
View all 49 locations
View Trial Details
Completed

A Study Investigating the Outcomes and Safety of Atezolizumab Under Real-World Conditions in Patients Treated in Routine Clinical Practice

NCT03782207

Conditions
Adenocarcinoma, Bronchial Neoplasms, Carcinoma, +22 more
Locations
  • Hospital Universitario Austral Buenos Aires, Argentina
  • Lucen S.A. Buenos Aires, Argentina
  • Consultorio Privado Korbenfeld CABA, Argentina
  • Hospital Italiano de Buenos Aires Ciudad Autonoma Buenos Aires, Argentina
View all 257 locations
View Trial Details
Completed

A Study of Participants in China With Non-Small-Cell Lung Cancer That is Unable to be Treated With Surgery

NCT05872763

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +7 more
Locations
  • Cancer Hospital Chinese Academy of Medical Sciences. Beijing, China
  • Beijing Chest Hospital Beijing, China
  • Sichuan Provincial Cancer Hospital Chengdu, China
  • Harbin Medical University Cancer Hospital Harbin, China
View Trial Details
Completed

Study to Evaluate the Bioavailability of Tislelizumab Via Subcutaneous Injection in First-Line Treatment of Participants With Advanced or Metastatic Non-Small Cell Lung Cancer

NCT06091943

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations
  • Cancer Hospital Chinese Academy of Medical Sciences Beijing, Beijing Municipality, China
  • Beijing Cancer Hospital Beijing, Beijing Municipality, China
  • Peking Union Medical College Hospital Beijing, Beijing Municipality, China
  • Fujian Cancer Hospital Fuzhou, Fujian, China
View all 15 locations
View Trial Details

Related conditions